Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliana Eng

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Chest|December 3, 2014
Personalized therapy for lung cancerAndre L Moreira, Juliana Eng
Journal of Graduate Medical Education|October 13, 2015
Patient Death Debriefing Sessions to Support Residents' Emotional Reactions to Patient DeathsJuliana Eng, Elizabeth Schulman, Sabrina M Jhanwar, et al.
Psychological Science|April 21, 2006
Spatial distance and mental construal of social eventsKentaro Fujita, Marlone D Henderson, Juliana Eng, et al.
Retinal Cases & Brief Reports|December 19, 2023
PLASMA CIRCULATING TUMOR DNA TO ASSIST IN THE DIAGNOSIS OF UNKNOWN PRIMARY MALIGNANCY UNDERLYING CHOROIDAL METASTASESJasmine H Francis, Sara Levine, Julia Canestraro, et al.
JTO Clinical and Research Reports|February 20, 2026
ALK Inhibitor Response in Novel <i>ZFPM2::ALK</i> and <i>TRIM24::ALK</i> Fusion-Positive Lung Cancers: Case ReportCharles Hsu, Mohamed Yakoub, Michael Offin, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancersJuliana Eng, Meier Hsu, Jamie E Chaft, et al.
JTO Clinical and Research Reports|July 3, 2026
Clinical Outcomes for Patients who Received Both Trastuzumab Deruxtecan (T-DXd) and Trastuzumab Emtansine (T-DM1) for HER2-Mutant non-Small Cell Lung CancerDaniel Reinhorn, Jonathan Kuten, Isabel Preeshagul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2015
Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung AdenocarcinomasJuliana Eng, Kaitlin M Woo, Camelia S Sima, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancerJamie E Chaft, Ibiayi Dagogo-Jack, Fernando C Santini, et al.
Oral Oncology|September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaLara A Dunn, Alan L Ho, Loren S Michel, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Chest|December 3, 2014
Personalized therapy for lung cancerAndre L Moreira, Juliana Eng
Journal of Graduate Medical Education|October 13, 2015
Patient Death Debriefing Sessions to Support Residents' Emotional Reactions to Patient DeathsJuliana Eng, Elizabeth Schulman, Sabrina M Jhanwar, et al.
Psychological Science|April 21, 2006
Spatial distance and mental construal of social eventsKentaro Fujita, Marlone D Henderson, Juliana Eng, et al.
Retinal Cases & Brief Reports|December 19, 2023
PLASMA CIRCULATING TUMOR DNA TO ASSIST IN THE DIAGNOSIS OF UNKNOWN PRIMARY MALIGNANCY UNDERLYING CHOROIDAL METASTASESJasmine H Francis, Sara Levine, Julia Canestraro, et al.
JTO Clinical and Research Reports|February 20, 2026
ALK Inhibitor Response in Novel <i>ZFPM2::ALK</i> and <i>TRIM24::ALK</i> Fusion-Positive Lung Cancers: Case ReportCharles Hsu, Mohamed Yakoub, Michael Offin, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancersJuliana Eng, Meier Hsu, Jamie E Chaft, et al.
JTO Clinical and Research Reports|July 3, 2026
Clinical Outcomes for Patients who Received Both Trastuzumab Deruxtecan (T-DXd) and Trastuzumab Emtansine (T-DM1) for HER2-Mutant non-Small Cell Lung CancerDaniel Reinhorn, Jonathan Kuten, Isabel Preeshagul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 4, 2015
Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung AdenocarcinomasJuliana Eng, Kaitlin M Woo, Camelia S Sima, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancerJamie E Chaft, Ibiayi Dagogo-Jack, Fernando C Santini, et al.
Oral Oncology|September 3, 2025
A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaLara A Dunn, Alan L Ho, Loren S Michel, et al.
Pageof 3